Univo announces preliminary results for 2021: Expects revenues of over ILS 74 million since establishment Univo expects to end Q4 with a turnover of over ILS 13 million – up 35% from Q4/2020 At the close of 2021, the company expects a sales turnover of over ILS 41 million, up 23% from Y2020 sales Univo has independent growing operations at Amit farm, and most of its Q4 revenues resulted from its home farm cultivation. Univo founder and CEO, Golan Bitton, said: “We expect 2021 growth to continue also into 2022 and 2023, with a crystal clear business strategy which includes access to end customers, direct sales to Clalit and Maccabi healthcare members, and future agreements for further imports from Tilray and other companies”